BCAL Diagnostics launches BREASTEST Monitor—blood test to monitor post-treatment breast cancer recurrence; 91% sensitivity, 95% NPV.
House Democrats touring the federal prison holding convicted child trafficker Ghislaine Maxwell compared the facility to a ...
Zacks Investment Research on MSN
LivaNova reports improved OSA outcomes with PolySync programming
LivaNova LIVN recently announced new data from the PolySync substudy showing that its PolySync programming algorithm ...
Purdue researchers developed a mass spectrometry platform that accelerates cancer drug discovery by integrating synthesis, ...
LivaNova’s proprietary PolySync algorithm allows for proximal hypoglossal nerve stimulation (p-HGNS) stimulation fields to be ...
LivaNova (Nasdaq:LIVN) today announced new data demonstrating the success of its PolySync programming algorithm for sleep ...
– Presentation at SLEEP 2026 illustrates ability to convert non-responders into responders using personalized programming ...
AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AK-AVS™ aortic valve stenosis (AVS) screening software has been accepted into the U.S. Food and Drug ...
For a decade, Tianjin has quietly built an end-to-end ecosystem for non-invasive brain-computer interface technology ranging ...
Advanced Analytics and Data Science department won first place at a recent Google Code for the Cure Hackathon in New York ...
Researchers are using AI to uncover hidden patterns in EEG recordings that could help diagnose epilepsy earlier.
New factor XIa inhibitors cut recurrent non-cardioembolic stroke without extra bleeding—plus what milvexian and abilacimab trials reveal. In this installment of this series, ‘The Future of Factor XIa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results